Eye Drop Company in FDA’s Sights Once Again
MedPage Today) — The FDA has sent another letter — this time a warning letter — to a company that it previously flagged for marketing amniotic fluid eye drops. In a letter to Carl Harrell, MD, CEO of Regenerative Processing Plant in Palm…
MedPage Today) — The FDA has sent another letter — this time a warning letter — to a company that it previously flagged for marketing amniotic fluid eye drops.
In a letter to Carl Harrell, MD, CEO of Regenerative Processing Plant in Palm…
Read More
About Author
